Rapid Procedure Growth With SurgiQuest's AirSeal System

MILFORD, Conn., June 3, 2015 /PRNewswire/ -- SurgiQuest®, Inc. ("SurgiQuest", the "Company"), a leading provider of innovative access technologies for minimally invasive surgery (MIS) announced today that surgeons have successfully used the AirSeal® System in over 250,000 procedures.  Adoption has risen rapidly with a 150% growth in global procedures over last year, driven by the company's expansion from robotics into the general laparoscopic market as well as geographic expansion to over 45 countries.  

The AirSeal System is fast becoming the standard of care for leading robotic and laparoscopic surgeons performing minimally invasive surgery.  It is ideal for MIS procedures in multiple specialties including Urology, Gynecology, Colorectal, Bariatric and General Surgery and is the only system that maintains stable pneumoperitoneum (abdominal insufflation) within a narrow range of the desired pressure during laparoscopic surgery.  This stability, along with continuous abdominal smoke evacuation, are two of the most important benefits driving continued adoption of the AirSeal System by worldwide thought leaders.

"We are extremely pleased with the rapid global expansion of the AirSeal System," said Kurt Azarbarzin, SurgiQuest's Founder and Chief Executive Officer.  "Our procedure volumes are increasing at an unprecedented rate adding 150,000 new procedures over the last year.   This strong and sustained growth demonstrates surgeons' increasing recognition of the significant clinical benefits that the AirSeal System provides for the surgeon and the patient."

About SurgiQuest, Inc.

SurgiQuest, Inc. is a privately held venture-backed company, founded in May 2006. The Company develops, manufactures and markets innovative access technologies for minimally invasive surgery. SurgiQuest's patented AirSeal System optimizes the laparoscopic environment and provides unparalleled stability in the abdominal cavity during MIS.  Unlike conventional insufflation and trocar systems, the Company's breakthrough integrated platform ensures stable pneumoperitoneum, continuously evacuates smoke and plume when energized medical devices such as electro-cautery, laser or ultrasound are used, and provides valve-free access to the abdominal cavity during both robotic and laparoscopic surgical procedures.  AnchorPort ®, Low Impact® Laparoscopy, AirSeal®, and SurgiQuest® are registered trademarks of SurgiQuest, Inc. All rights reserved.   Additional information about SurgiQuest products can be found at www.surgiquest.com.

Logo - http://photos.prnewswire.com/prnh/20140113/NY44266LOGO 

SOURCE SurgiQuest, Inc.

Related Links

http://www.surgiquest.com